| CTRI Number |
CTRI/2025/07/090686 [Registered on: 10/07/2025] Trial Registered Prospectively |
| Last Modified On: |
10/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Measuring saliva levels of YKL-40 and LL-37 in children with Down syndrome: A study of 8 - 15 years old. |
|
Scientific Title of Study
|
Evaluation of YKL-40 and LL-37 levels in saliva of children with Down syndrome: A cross sectional study. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Prapti Subhash Gayakwad |
| Designation |
Post Graduate Student |
| Affiliation |
The Oxford Dental College Bangalore |
| Address |
Bommabahalli, NH 44 Hongasandra , Bengaluru, Cauvery Serenity , Yeshwanthpur Industrial Area, 560022 Bangalore KARNATAKA 560068 India |
| Phone |
09742679736 |
| Fax |
9742679736 |
| Email |
prapti6198@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR MADHUSUDHAN. K . S |
| Designation |
READER |
| Affiliation |
The Oxford Dental College Bangalore |
| Address |
THE OXFORD DENTAL COLLEGE, BOMMANAHALI, BANGALORE, KARNATAK ,560068 THE OXFORD DENTAL COLLEGE, BOMMANAHALI, BANGALORE, KARNATAK ,560068 Bangalore KARNATAKA 560068 India |
| Phone |
9886035137 |
| Fax |
9886035137 |
| Email |
sudhannks@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Prapti Subhash Gayakwad |
| Designation |
Post Graduate Student |
| Affiliation |
The Oxford Dental College Bangalore |
| Address |
Bommabahalli, NH 44 Hongasandra , Bengaluru, Cauvery Serenity , Yeshwanthpur Industrial Area, 560022 Bangalore KARNATAKA 560068 India |
| Phone |
09742679736 |
| Fax |
9742679736 |
| Email |
prapti6198@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr. Prapti Subhash Gayakwad
Memera plaza AECS B Block , Wellington paradise, Singhsandra, Bangalore, Karnataka, 560068 |
|
|
Primary Sponsor
|
| Name |
Dr Prapti Subhash Gayakwad |
| Address |
Menera Plaza Singhsandra , AECS B Bloc, Wellington Paradise, Bangalore, Karnataka, India 560068 |
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prapti Subhash Gayakwad |
The Oxford Dental College |
The Oxford Dental College Room no. 8 fourth floor Bommabahalli, NH 44 Hongasandra , Bengaluru 560068 Bangalore KARNATAKA |
9742679736 9742679736 prapti6198@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| THE OXFORD DENTAL COLLEGE INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: Q909||Down syndrome, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
nil |
nil |
|
|
Inclusion Criteria
|
| Age From |
8.00 Year(s) |
| Age To |
15.00 Year(s) |
| Gender |
Both |
| Details |
1. Children with Down Syndrome in the age group of 8 to 15years.
2. Cooperative children based on Frankel behaviour rating scale 3 and 4 |
|
| ExclusionCriteria |
| Details |
1. Children on long term medication
2. Down syndromic children who were extremely uncooperative
3. Children if they had taken antibiotics or anti inflammatory drugs
4. Children with severs intellectual disability and or cardiac condition present along with Down Syndrome. |
|
|
Method of Generating Random Sequence
|
Stratified randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Double Blind Double Dummy |
|
Primary Outcome
|
| Outcome |
TimePoints |
| 8 weeks |
base line |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Inflammatory biomarker levels will be higher in Down syndrome patients. |
One year |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
10/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="2" Days="1" |
|
Recruitment Status of Trial (Global)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [prapti6198@gmail.com].
- For how long will this data be available start date provided 14-04-2024 and end date provided 14-07-2025?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
This study is a cross sectional study, double blinded, single center trial comparing the levels of YKL-40 and LL-37 levels in the saliva of children with Down syndrome and healthy children in 8 to 15 years old children that will be conducted in India. This study will be carried over the period of six months, and the saliva sample collection will be done in Coachmans position. The samples will be stored in -80 degrees after centrifugation. After collection of all the samples they will be sent for ELISA running and the data will be subjected to the statistical analysis. |